In an early report from brainstem glioma, the expression of β-catenin and E-/N-cadherin in patient samples revealed no obvious staining for E-cadherin, but higher β-catenin and N-cadherin levels in high-grade tumours, and worse outcomes indicated the EMT’s involvement in glioma aggressive behaviour [130]. This evidence concerns the gene CDH2 and central nervous system cancer.